中药产业创新生态系统演进与创新主体变迁——以安徽省黄精产业为例

李爱玉; 李金洪; 李雪燕; 丰志培

doi:10.20251/j.cnki.1003-3734.2026.10.003

中国新药杂志 ›› 2026, Vol. 35 ›› Issue (10) : 1024 -1031. DOI: 10.20251/j.cnki.1003-3734.2026.10.003

新药述评与论坛

中药产业创新生态系统演进与创新主体变迁——以安徽省黄精产业为例

^1,2

^1,2*

作者信息 +

Evolution and subject transformation of traditional Chinese medicine industry from the perspective of industrial innovation ecosystem: a case study of Polygonati Rhizoma industry in Anhui province

^1,2

^1,2*

Author information +

文章历史 +

PDF (1222K)

摘要

目的: 中药产业发展问题源于创新动力不足,产业创新生态系统研究有利于解决此类问题。解析系统演进及其创新主体变迁并提出战略选择路径,有利于推动中药产业创新生态系统演进,为提升产业创新能力和竞争力提供参考。方法: 在厘清中药产业创新生态系统构成与互动模式的基础上,以安徽省黄精产业为例,分析系统演进1.0、2.0、3.0三个阶段中,创新主体从高校、研发机构等创新个体向“政府-企业-学研”创新种群,再向“政府-企业-学研-用户”创新群落变迁的过程。结果: 安徽省黄精产业创新生态系统已经历技术创新推动的1.0阶段、政策引导下的2.0阶段,市场拉动下的3.0阶段尚未完成。演进障碍来自研发型企业(医院等)创新生产者产品创新不足、中介机构(销售企业等)创新分解者信息平台搭建不完善、制造企业(种植户等)创新消费者缺失引发产业链协同失效。结论: 只有研发型企业推动产品创新、中介机构完善信息平台、制造企业引领产业链协同,才能驱动产业创新生态系统3.0最终形成。

Abstract

Objective: To conduct a theoretical research of industrial innovation ecosystem to solve the problems in the development of traditional Chinese medicine industry which stem from the lack of innovation motivation and the blockage of the construction of innovation ecosystem. Methods: This paper analyzed the evolution of the system and the changes of the role of the innovation subject in the evolution, and put forward the effective strategic choice path, so as to promote the evolution of traditional Chinese medicine industry innovation ecosystem, and to provide references for improving the innovation and competitiveness of traditional Chinese medicine industry. On the basis of clarifying the composition and interaction mode of the innovation ecosystem of traditional Chinese medicine industry, this paper analyzed the changing characteristics of innovation subjects in the three stages of system innovation evolution 1.0, 2.0 and 3.0 in Huangjing (Polygonati Rhizoma) industry of Anhui Province. Innovation individuals led by scientific research, formed by innovation producers such as universities, research and development institutions and R&D enterprises, and changed into innovation groups formed by the service of intermediary institutions, financial institutions, government and other innovation disintegrators, and then changed into innovation community, facilitated by innovation consumers composed of large enterprises and the public. Results: The research showed that P.rhizoma industry innovation ecosystem in Anhui Province has gone through the 1.0 stage driven by technological innovation and the 2.0 stage guided by policies, but the 3.0 stage driven by market pull has not been completed. The obstacles to its evolution arised from the insufficient product innovation of innovative producers such as R&D-oriented enterprises and hospitals, the imperfect construction of information platforms for innovative decomposers such as intermediary agencies and sales enterprises, and the failure of industrial chain collaboration caused by the absence of innovative consumers such as manufacturing enterprises and growers. Conclusion: The final formation of the industrial innovation ecosystem 3.0 can only be driven by R&D enterprises promoting product innovation, intermediary agencies improving information platforms, and manufacturing enterprises leading industrial chain collaboration.